ZD9-20329-79765 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-04
Registered in v-safe
2021-04-04
Dose 1 — Pfizer-BioNTech
2021-04-04
Survey response — day 0, dose 1
MedDRA: Hot flush — Feeling: Good · Site: Pain

Free text: Hot flashes

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-05
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness

Adult check-in
2021-04-06
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Fatigue or tiredness

Adult check-in
2021-04-07
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-04-08
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · None

Adult check-in
2021-04-09
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-04-10
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-04-11
Health check-in — day 7, dose 1
Feeling: Fair · None

Adult check-in
2021-04-19
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-04-25
Dose 2 — Pfizer-BioNTech
2021-05-09
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-05-16
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-05-23
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-07-27
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-10-24
Survey response — 6 months, dose 2
MedDRA: Epistaxis — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Random nose bleeds

MedDRA releases: 2024-11 · check-in free text available
2021-10-24
Report sent to call center — 6 months, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2021-10-26
Call 1 — Could Not Reach Participant
2021-10-29
Call 2 — Could Not Reach Participant
2022-01-06
Dose 3 — Pfizer-BioNTech
2022-04-25
Survey response — 12 months, dose 2
MedDRA: Cautery to nose, Epistaxis — Feeling: Good · Be unable to work or attend school

Free text: Nose bleeds which I had to have my nose cauterized

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-04	Pfizer-BioNTech
2	2021-04-25	Pfizer-BioNTech
3	2022-01-06	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2021-10-24	Unsuccessful

Free text

Release 6 — day 0, dose 1

2021-04-04

Systemic reaction (other): Hot flashes

Release 10 — 6 months, dose 2

2021-10-24

Symptoms: Random nose bleeds

Release 11 — 12 months, dose 2

2022-04-25

Symptoms: Nose bleeds which I had to have my nose cauterized

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Cautery to nose	·	·	✓
SD	Epistaxis	·	·	✓
SRO	Hot flush	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release